Skip to content

PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes

PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes in Obese Women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07366944
Enrollment
40
Registered
2026-01-26
Start date
2025-12-05
Completion date
2026-06-05
Last updated
2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye, Obesity, Polycystic Ovary Syndrome

Brief summary

Women with polycystic ovarian syndrome (PCOS) may complain dryness of their eyes especially obese ones. lifestye changes are main treatrment fro both problems

Detailed description

Forty females with PCOS, eye dryness , and obesity will asigned to group I or Group II, n=20 for each group. Both groups will receive metformin thrice times daily and low calorie diet for 12 weeks. Group I, additionally will perform one hour of treadmill walking thrice weekly for 12 weeks.

Interventions

BEHAVIORALexercise and limiting diet

twenty females with PCOS, eye dryness , and obesity will receive metformin thrice times daily and low calorie diet for 12 weeks. Group I, additionally will perform one hour of treadmill walking thrice weekly for 12 weeks.

BEHAVIORALdiet limitation

twenty females with PCOS, eye dryness , and obesity will receive metformin thrice times daily and low calorie diet for 12 weeks.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* PCOS women * obese class I * bilateral dryness of eye

Exclusion criteria

* liver disoease * cardiac disease * renal disease

Design outcomes

Primary

MeasureTime frameDescription
schrimer testit will be measured after 12 weeksit is a test for assessment dye dryness

Secondary

MeasureTime frameDescription
Ocular surface disability indexIt will be measured after 12 weeksit is a questionaire for assessment dye dryness
dry eye scoring systemIt will be measured after 12 weeksit is a questionaire for assessment dye dryness
Tear film break-up timeIt will be measured after 12 weeksit is a test for assessment dye dryness
body mass indexit will be measured after 12 weeksit will be assessed on empty stomach and bowel
wasit hip ratioIt will be measured after 12 weeksit will be assessed by dividing wasit circuference on hip circumference
wasit circumferenceIt will be measured after 12 weeksit will be assessed by tape measure
testesteroneIt will be measured after 12 weeksit will be assessed in serum
LH:FSH ratioIt will be measured after 12 weeksThe LH (Luteinizing Hormone) to FSH (Follicle-Stimulating Hormone) ratio shows the balance between these reproductive hormones
dehydroepiandrosteroneIt will be measured after 12 weeksit will ne assessed in serum

Countries

Egypt

Contacts

CONTACTAli MA Ismail, lecturer
ali.mohamed@pt.cu.edu.eg01005154209
CONTACTAli Ismail
allooka2012@gmail.com01031321109
PRINCIPAL_INVESTIGATORAli MA Ismail, lecturer

Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026